Summer Dewdney, MD
Gynecologic Oncology · Chicago, ILNPI 1922243211
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by GSK at 36.9% of the total. Reporting peaked in 2019 at $15,805 and has fallen 62.7% since, to $5,889 in 2025. Among gynecologic oncology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 69 payments — averaging $856.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$22K
- AstraZeneca$22K
- Merck$9K
- Seagen Inc.$5K
- Intuitive Surgical$1K
- Immunogen, Inc.$138
- plus $76 from 1 others
Across 77 payments — averaging $2365.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$82K
- AbbVie$44K
- Merck$28K
- Alkermes, Inc.$23K
- Eisai Inc.$3K
- Novocure Inc.$2K
What the payments were for
- Consulting fees$33,24656%
- Speaking & faculty fees$17,03529%
- Travel & lodging$6,93012%
- Food & beverage$1,8893%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 23 | $21,816 |
| AstraZeneca | 23 | $21,736 |
| Merck | 8 | $9,266 |
| Seagen Inc. | 4 | $4,768 |
| Intuitive Surgical | 8 | $1,311 |
| Immunogen, Inc. | 1 | $138 |
| Tesaro, Inc. | 2 | $76 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$59,111 in reported general payments places this provider in the 90th percentile of 64 gynecologic oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Chicago
- Amina AhmedChicago$1.1M
- Dario RoqueChicago$587K
- Jenna MarcusChicago$230K
- Emily HinchcliffChicago$62K
- Kathryn MillsChicago$32K
- Wilberto Nieves-NeiraChicago$23K
- Amy AlexanderChicago$22K
- Freidoon AziziChicago$14K
- John MoroneyChicago$8K
- Emma BarberChicago$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.